Chiesi Announces Results of the Tanimilast Phase III PILASTER Clinical Study in Chronic Obstructive Pulmonary Disease (COPD)
23 September 2025
ISO 37001:2016 Certification: Chiesi Farmaceutici Starts the Extension Process of the Certification to the Affiliates of the Group
08 May 2025